Testicular cancer: What's new in staging, prognosis, and therapy - The Foster/Nichols article reviewed

被引：0
作者：
Borner, MM [1 ]
Studer, UE
机构：
[1] Univ Bern, Inst Med Oncol, CH-3012 Bern, Switzerland
[2] Univ Bern, Dept Urol, CH-3012 Bern, Switzerland
来源：
ONCOLOGY-NEW YORK | 1999年 / 13卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1698 / 1700
页数：3
相关论文
共 15 条
  • [1] Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors
    Baniel, J
    Roth, BJ
    Foster, RS
    Donohue, JP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (01) : 86 - 93
  • [2] Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors
    Böhlen, D
    Borner, M
    Sonntag, RW
    Fey, MF
    Studer, UE
    [J]. JOURNAL OF UROLOGY, 1999, 161 (04) : 1148 - 1152
  • [3] THE LATE EFFECTS OF GERM-CELL TUMOR-CHEMOTHERAPY - MORE DATA ARE NEEDED
    BOSL, GJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) : 1375 - 1376
  • [4] Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A medical research council report
    Cullen, MH
    Stenning, SP
    Parkinson, MC
    Fossa, SD
    Kaye, SB
    Horwich, AH
    Harland, SJ
    Williams, MV
    Jakes, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1106 - 1113
  • [5] CULLEN MH, 1995, BR J CANC S21, V69, P14
  • [6] THE ROLE OF RETROPERITONEAL LYMPHADENECTOMY IN CLINICAL STAGE-B TESTIS CANCER - THE INDIANA-UNIVERSITY EXPERIENCE (1965 TO 1989)
    DONOHUE, JP
    THORNHILL, JA
    FOSTER, RS
    BIHRLE, R
    ROWLAND, RG
    EINHORN, LH
    [J]. JOURNAL OF UROLOGY, 1995, 153 (01) : 85 - 89
  • [7] EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL
    EINHORN, LH
    WILLIAMS, SD
    LOEHRER, PJ
    BIRCH, R
    DRASGA, R
    OMURA, G
    GRECO, FA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 387 - 391
  • [8] DETECTION OF RECURRENCE IN PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS AND CONSEQUENCES FOR FURTHER FOLLOW-UP - A SINGLE-CENTER 10-YEAR EXPERIENCE
    GELS, ME
    HOEKSTRA, HJ
    SLEIJFER, DT
    MARRINK, J
    DEBRUIJN, HWA
    MOLENAAR, WM
    FRELING, NJM
    DROSTE, JHJ
    KOOPS, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1188 - 1194
  • [9] Nicholas JJ, 1993, J PROSTHET ORTHOT, V5, P16
  • [10] DEFINING NEW STANDARDS FOR ADJUVANT THERAPY OF TESTIS CANCER
    NICHOLS, CR
    GONIN, R
    FOSTER, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2681 - 2683
12